Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate b...

Basic Information

ID: ALA1837250

Type: Binding

Description: Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate by Michaelis-Menten method

Format: BAO_0000357

Organism: Homo sapiens

Target: Cathepsin B(ALA4072)

Document: ALA1833856

Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate by Michaelis-Menten method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA1837250

Total(8)

Parent Molecular Weight	ALogP	Polar Surface Area
279.39	2.57	2.57
293.42	2.96	2.96
307.44	3.35	3.35
290.37	2.07	2.07
309.37	1.63	1.63
305.43	2.96	2.96
319.46	3.35	3.35
333.48	3.74	3.74

Parent Molecular Weight

ALogP

Polar Surface Area

279.39

2.57

293.42

2.96

307.44

3.35

290.37

2.07

309.37

1.63

305.43

2.96

319.46

3.35

333.48

3.74

Mixed-type inhibition of human recombinant cathepsin B assessed as formation of fluorescent degradation product AMC using Z-Arg-Arg-AMC as substrate b...

Basic Information

Activity Charts

Compound Summary